Table 1 Comparison of baseline characteristics at admission between patients with Sham and PMES groups
| Â | Sham group (133) | PMES group (125) | OR(95%CI) | P* |
|---|---|---|---|---|
Age, y (Mean SD) | 66.11 ± 8.37 | 65.0 ± 8.82 |  | 0.622 |
NIHSS, (Mean SD) | 6.99 ± 2.47 | 7.02 ± 2.21 |  | 0.978 |
Females, n(%) | 68 (51.13) | 55 (44.00) | 0.751 (0.46–1.23) | 0.465 |
Men, n(%) | 65 (48.87) | 70 (56.00) | 0.751 (0.46–1.23) | 0.252 |
BMI ≥ 24 kg/m, n(%) | 32 (24.06) | 42 (33.60) | 1.60 (0.93–2.75) | 0.090 |
Hypertension, n(%) | 72 (54.14) | 76 (60.8) | 1.31 (0.80–2.16) | 0.279 |
Current Smoking, n(%) | 48 (36.09) | 43 (34.40) | 0.93 (0.56–1.55) | 0.776 |
Current Drinking, n(%) | 43 (32.33) | 44 (33.08) | 1.14 (0.68–1.91) | 0.626 |
Diabetes, n(%) | 54 (40.60) | 43 (34.40) | 0.77 (0.46–1.27) | 0.304 |
Hyperlipidemia, n(%) | 65 (48.87) | 74 (59.20) | 1.52 (0.93–2.45) | 0.096 |
Atrial fibrillation, n(%) | 50 (37.59) | 40 (30.08) | 0.78 (0.47–1.31) | 0.346 |
Family history of stroke, n(%) | 29 (21.80) | 33 (26.40) | 1.29 (0.73–2.28) | 0.388 |
MoCA Score, (mean SD) | 24.90 ± 3.16 | 24.90 ± 2.82 |  | 0.936 |
HRSD Score, (mean SD) | 22.02 ± 4.54 | 21.51 ± 4.32 |  | 0.280 |
Medications use | ||||
 Antiplatelet, n(%) | 43 (32.33) | 48 (38.40) | 1.31 (0.78–2.17) | 0.308 |
 Antihypertensive, n(%) | 56 (42.11) | 56 (44.80) | 1.12 (0.68–1.83) | 0.663 |
 lipid-lowering medications, n(%) | 64 (48.12) | 71 (56.80) | 1.42 (0.87–2.32) | 0.163 |
 Sertraline, n(%) | 83 (62.41) | 81 (60.90) | 1.11 (0.67–1.84) | 0.690 |
 Escitalopram, n(%) | 14 (10.53) | 19 (14.29) | 1.52 (0.73–3.19) | 0.261 |
 Paroxetine, n(%) | 36 (27.07) | 25 (18.80) | 0.67 (0.38–1.21) | 0.182 |
Infarct location | ||||
 Basal ganglia, n(%) | 62 (46.62) | 61 (45.86) | 1.09 (0.67–1.78) | 0.726 |
 Brain stem, n(%) | 18 (13.53) | 20 (15.04) | 1.22 (0.611–2.43) | 0.576 |
 Cerebellum, n(%) | 10 (7.52) | 4 (3.01) | 0.41 (0.12–1.33) | 0.126 |
 Frontal lobe, n(%) | 19 (14.29) | 15 (11.28) | 0.82 (0.40–1.69) | 0.588 |
 Parietal lobe, n(%) | 10 (7.52) | 9 (6.77) | 0.95 (0.37–2.43) | 0.922 |
 Temporal lobe, n(%) | 5 (3.76) | 10 (8.00) | 2.23 (0.74–6.71) | 0.146 |
 Occipital lobe, n(%) | 9 (6.77) | 6 (4.80) | 0.70 (0.24–2.01) | 0.500 |